LUNG CANCER (NON-SMALL CELL)
Clinical trials for LUNG CANCER (NON-SMALL CELL) explained in plain language.
Never miss a new study
Get alerted when new LUNG CANCER (NON-SMALL CELL) trials appear
Sign up with your email to follow new studies for LUNG CANCER (NON-SMALL CELL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Exercise as medicine: tailored workouts may rebuild strength after cancer
Disease control Recruiting nowThis trial tests whether a personalized exercise program can safely help cancer survivors improve their physical fitness and quality of life. Participants who have finished curative treatment at least two months ago will receive a tailored plan based on heart, lung, and muscle as…
Matched conditions: LUNG CANCER (NON-SMALL CELL)
Phase: NA • Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New drug combo aims to shrink tough lung cancers
Disease control Recruiting nowThis Phase 2 trial tests a drug called ivonescimab, either alone or with chemotherapy, in people with advanced non-small cell lung cancer that has certain genetic changes. The study aims to see if the treatment can shrink tumors and control the cancer. About 46 participants will …
Matched conditions: LUNG CANCER (NON-SMALL CELL)
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New cell therapy trial hopes to tackle tough cancers
Disease control Recruiting nowThis early-phase trial tests SL-28, a cell therapy made from donor immune cells, in 60 people with advanced solid tumors (like lung, pancreatic, or breast cancer) that haven't responded to standard treatments. The study aims to find a safe dose and see if the therapy can shrink t…
Matched conditions: LUNG CANCER (NON-SMALL CELL)
Phase: PHASE1, PHASE2 • Sponsor: Second Life Therapeutics • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New drug SKB571 targets advanced lung cancer in Mid-Stage trial
Disease control Recruiting nowThis phase 2 study tests a new drug called SKB571 in 295 people with advanced non-small cell lung cancer. The drug is given every three weeks to see if it can shrink tumors and how safe it is. The goal is to find a better treatment option for this serious disease.
Matched conditions: LUNG CANCER (NON-SMALL CELL)
Phase: PHASE2 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New hope for KRAS-driven lung cancer: drug duo targets tough mutation
Disease control Recruiting nowThis study tests a combination of two drugs (IBI351 and cetuximab β) in people with advanced non-small cell lung cancer that has a specific genetic change called KRAS G12C. About 48 participants will receive the treatment to see if it shrinks tumors and how safe it is. The goal i…
Matched conditions: LUNG CANCER (NON-SMALL CELL)
Phase: PHASE2 • Sponsor: Guangdong Association of Clinical Trials • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New Antibody-Drug conjugate targets Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new drug called MBRC-201 in people with advanced solid tumors (prostate, breast, colorectal, lung, or pancreatic cancer) that have not responded to standard treatments. The drug is an antibody-drug conjugate, designed to deliver a cancer-killing agent directly …
Matched conditions: LUNG CANCER (NON-SMALL CELL)
Phase: PHASE1, PHASE2 • Sponsor: MBrace Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Inhaled virus takes on lung tumors in new trial
Disease control Recruiting nowThis study tests an inhaled treatment called KB707, a modified herpes virus designed to trigger the immune system against lung tumors. It is for adults with advanced solid tumors that have spread to the lungs and who have run out of standard options. The trial will test KB707 alo…
Matched conditions: LUNG CANCER (NON-SMALL CELL)
Phase: PHASE1, PHASE2 • Sponsor: Krystal Biotech, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Veterans with lung cancer get weekly check-in calls to boost quality of life
Symptom relief Recruiting nowThis study tests whether regular phone support from a trained lay health worker can improve quality of life for veterans with lung cancer. 194 veterans will either receive usual care or weekly calls for 6 months. The goal is to see if this extra support helps with healthcare plan…
Matched conditions: LUNG CANCER (NON-SMALL CELL)
Phase: NA • Sponsor: Palo Alto Veterans Institute for Research • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Can a simple check of nutrition and muscle predict lung surgery outcomes?
Knowledge-focused Recruiting nowThis study follows 142 adults having lung cancer surgery to see if measuring nutrition and muscle loss can help predict complications, hospital stay, and survival. Participants get blood tests, CT scans, and ultrasound before surgery. The goal is to create a better risk score to …
Matched conditions: LUNG CANCER (NON-SMALL CELL)
Sponsor: Ondokuz Mayıs University • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC
-
Mapping Cancer's evolution: a study to outsmart treatment resistance
Knowledge-focused Recruiting nowThis study follows 600 people with lung cancer or mesothelioma to track how their tumors evolve during and after treatment. Researchers collect blood, tissue, and imaging samples every few months to understand why some cancers come back or stop responding to therapy. The goal is …
Matched conditions: LUNG CANCER (NON-SMALL CELL)
Sponsor: University College, London • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC
-
New belt may help lung cancer patients get more precise radiation
Knowledge-focused Recruiting nowThis study tests a new abdominal pressure device that helps limit breathing movement during radiation therapy for lung cancer. Researchers want to see if it safely reduces tumor motion, making treatment more accurate. About 50 adults with early-stage lung cancer will take part. T…
Matched conditions: LUNG CANCER (NON-SMALL CELL)
Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Robotic vs. video surgery: which is better for lung cancer?
Knowledge-focused Recruiting nowThis study looks at two types of minimally invasive surgery for central lung cancer: robotic-assisted (RATS) and video-assisted (VATS). Researchers want to see which one helps patients live longer without cancer coming back. About 450 adults with non-small cell lung cancer will t…
Matched conditions: LUNG CANCER (NON-SMALL CELL)
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Sweat it out: exercise may help fight lung cancer from within
Knowledge-focused Recruiting nowThis study tests whether short-term, strenuous exercise before lung cancer surgery can change the tumor's immune environment. Researchers will compare tumor samples from 48 patients who exercise versus those who don't. The goal is to see if exercise boosts immune-related signals …
Matched conditions: LUNG CANCER (NON-SMALL CELL)
Phase: NA • Sponsor: University of Arizona • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Can a blood test or Mini-Tumor predict immunotherapy success in lung cancer?
Knowledge-focused Recruiting nowThis study is testing whether special lab tools—like analyzing tiny particles from blood cells or growing mini-tumors in a dish—can predict how well immunotherapy drugs work in people whose lung cancer has returned. About 40 participants will receive standard immunotherapy drugs …
Matched conditions: LUNG CANCER (NON-SMALL CELL)
Phase: PHASE1, PHASE2 • Sponsor: GlaxoSmithKline • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Immunotherapy before surgery: which next step works best for lung cancer?
Knowledge-focused Recruiting nowThis study follows 500 lung cancer patients who received immunotherapy before their main treatment. Researchers want to see whether surgery (removing part or all of a lung) or non-surgery options like radiation lead to better long-term outcomes. The goal is to find the best appro…
Matched conditions: LUNG CANCER (NON-SMALL CELL)
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:25 UTC